Clinical Trial Update: Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing neoadjuvant therapy to upfront surgery for left-sided resectable pancreatic cancer; sponsor is Helsinki University Central Hospital, sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Pancreatic Cancer Resectable | Phase 3 | Status: NOT_YET_RECRUITING